Globus Medical traded at $86.49 this Thursday March 26th, decreasing $0.86 or 0.98 percent since the previous trading session. Looking back, over the last four weeks, Globus Medical lost 9.40 percent. Over the last 12 months, its price rose by 17.42 percent. Looking ahead, we forecast Globus Medical to be priced at 84.73 by the end of this quarter and at 77.33 in one year, according to Trading Economics global macro models projections and analysts expectations.
Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.